Table 2.
Comparison of COVID-19-related and unrelated acute ischemic stroke patients by TOAST classification and infarct size
|
COVID-19-related acute stroke
n=19 |
COVID-19-unrelated acute stroke
n=146 |
p | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| TOAST classification | |||||
| Large-artery atherosclerosis | 4 | 21.1 | 24 | 16.4 | 0.512 |
| Cardioembolism | 5 | 26.3 | 29 | 19.9 | |
| Small-vessel occlusion | 1 | 5.3 | 27 | 18.5 | |
| Other determined etiology | 0 | 0 | 0 | 0 | |
| Stroke of undetermined etiology | 9 | 47.4 | 66 | 45.2 | |
| Infarct size | |||||
| Small | 2 | 10.5 | 48 | 32.9 | 0.003 |
| Medium | 6 | 31.6 | 66 | 45.2 | |
| Large | 11 | 57.9 | 32 | 21.9 | |
TOAST: Trial of org 10172 in acute stroke treatment.